Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.05    -0.70 (-8.00%)
Bid:
8.05
Ask:
8.75
Spread: 0.70 (8.696%)
Market Cap: £93.04m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Pre Stabilisation Notice

2 Nov 2021 13:38

RNS Number : 1012R
HSBC Bank plc
02 November 2021
 

2nd November 2021

 

SIG plc 

Pre Stabilisation Notice

HSBC (contact: 'synd manager'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

SIG plc

Guarantor (if any):

na

Aggregate nominal amount:

EUR 300,000,000

Description:

Fixed 5yr

Offer price:

TBC

Other offer terms:

 

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

4th November 2021

Stabilisation period expected to end no later than:

10th December 2021

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFZMGMFZKGMZM
Date   Source Headline
1st Feb 20237:00 amRNSDirectorate Change
10th Jan 20237:00 amRNS2022 Full Year Trading Update
16th Dec 20228:04 amRNSDirector Declaration
15th Sep 202210:49 amRNSDirectorate Changes
13th Sep 20224:59 pmRNSDirector/PDMR Shareholding
8th Sep 20227:00 amRNSCEO Steve Francis to be succeeded by Gavin Slark
9th Aug 20227:00 amRNSHalf-year Report
25th Jul 20227:00 amRNSAcquisition of Miers Construction Products Limited
1st Jul 20229:38 amRNSNotice of Half Year Results
22nd Jun 20229:53 amRNSChange of Adviser
12th May 20226:11 pmRNSResult of AGM
12th May 20222:52 pmRNSResult of AGM
29th Apr 20227:00 amRNSTrading Update
12th Apr 20223:21 pmRNSDirector/PDMR Shareholding
8th Apr 20223:28 pmRNSDirector/PDMR Shareholding
8th Apr 20223:25 pmRNSDirector/PDMR Shareholding
28th Mar 20223:14 pmRNSNotice of AGM
16th Mar 202212:24 pmRNSDirector/PDMR Shareholding
15th Mar 20224:41 pmRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNSAnnual Financial Report
11th Mar 20227:00 amRNSFull year results for the year ended 31 Dec 21
7th Mar 20224:16 pmRNSHolding(s) in Company
11th Jan 20227:00 amRNSFull Year Trading Update
17th Dec 20214:35 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSTrading Update
13th Dec 202111:15 amRNSDirector/PDMR Shareholding
2nd Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20213:28 pmRNSDirector/PDMR Shareholding
12th Nov 202112:16 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSPricing of EUR300,000,000 Senior Secured Notes
2nd Nov 20211:38 pmRNSPre Stabilisation Notice
1st Nov 20217:52 amRNSProposed Refinancing Transactions
22nd Oct 20217:00 amRNSTrading Statement
6th Oct 20214:54 pmRNSDirector/PDMR Shareholding
21st Sep 20217:00 amRNSResults for the 6 months to 30 June 2021
14th Jul 20217:00 amRNSTrading Update
16th Jun 202110:59 amRNSShare Capital Reduction Confirmation
14th May 20212:51 pmRNSDirectorate Change
13th May 20214:18 pmRNSNotice of Results
5th May 20217:00 amRNSTrading Statement
12th Apr 20214:54 pmRNSDirector/PDMR Shareholding amendment
12th Apr 202112:51 pmRNSDirector/PDMR Shareholding
8th Apr 20219:04 amRNS2020 Annual Report & Accounts and Notice of AGM
31st Mar 20219:11 amRNSDirector/PDMR Shareholding
31st Mar 20219:05 amRNSDirector/PDMR Shareholding
31st Mar 20219:03 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSFull year results
2nd Mar 20217:00 amRNSNotice of 2020 Full Year Results
28th Jan 20219:00 amRNSAppointment of new Non-Executive Director
11th Jan 20217:00 amRNSFull Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.